Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. (Q53276513)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 January 2011
edit
Language Label Description Also known as
English
Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
scientific article published on 10 January 2011

    Statements

    Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit